企業プロフィール
Acurx Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- ACXP
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.47 USD (+1.38%)
終値
最終更新: 2026年8月21日
7.74M USD
時価総額
株価変動の要因
As of Aug 21, 2026, ACXP closed up 1.38% at $1.47. No new same-company headline was identified in the current news window.
企業概要
事業概要
Acurx Pharmaceuticals is an anti-infective company focused on novel antibiotics for bacterial infections. Its platform is aimed at addressing antibiotic resistance in difficult pathogens.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Acurx sits in specialty biopharma.
ビジネスモデルの特徴
The company depends on clinical data, anti-infective differentiation, and the commercial opportunity in resistant infections.
バイオ業界での位置付け
Acurx is a niche anti-infective name whose valuation depends on regulatory and development progress.
今後のカタリスト
- Acurx’s catalysts are ibezapolstat and the recurrent C. difficile program, along with any regulatory or development step that keeps the oral-antibiotic story moving. The company remains highly dependent on clinical progress.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。